In the present study, we found that AME can cause S-phase arrest of breast cancer cells, downregulate the expression of CDC20, AURKB, PLK1, CCNB2, and TOP2A, and upregulate the expression of GADD45A, eventually inhibiting the proliferation of breast cancer cells. The gene discussed is PLK1; the disease is breast carcinoma.